# HYOU1

## Overview
The HYOU1 gene encodes the hypoxia up-regulated 1 protein, a chaperone primarily located in the endoplasmic reticulum and mitochondria. This protein plays a pivotal role in cellular homeostasis, particularly under stress conditions such as hypoxia and oxidative stress. As a chaperone, it is involved in the proper folding of proteins and the cellular response to stress, including the unfolded protein response (UPR). The hypoxia up-regulated 1 protein is crucial for protecting cells from hypoxia-induced apoptosis and is involved in processes such as angiogenesis and neuroprotection. It interacts with various cytokines and modulates signaling pathways, including the JAK/STAT pathway, which is essential for cell survival and migration. The protein's ATPase domain is vital for its function, facilitating ATP hydrolysis necessary for conformational changes and substrate binding, thereby managing protein interactions and cellular stress responses (Giffin2014Modulation; Haapaniemi2017Combined).

## Function
The HYOU1 gene encodes a chaperone protein that is primarily localized in the endoplasmic reticulum (ER) and mitochondria, where it plays a critical role in maintaining cellular homeostasis under stress conditions. In healthy human cells, HYOU1 is involved in the proper folding of proteins and the cellular response to stress, including oxidative stress and the unfolded protein response (UPR) (Haapaniemi2017Combined). The protein's ATPase domain is essential for its function, facilitating ATP hydrolysis necessary for conformational changes and substrate binding. This activity is crucial for managing protein interactions and cellular stress responses (Haapaniemi2017Combined).

HYOU1 is also implicated in the cellular response to hypoxia, where it protects cells from hypoxia-induced apoptosis and is involved in processes such as angiogenesis and neuroprotection (Giffin2014Modulation). It interacts with various cytokines, modulating signaling pathways like the JAK/STAT pathway, which is important for cell survival and migration (Giffin2014Modulation). The protein's role in these processes highlights its importance in maintaining metabolic balance and immune function, particularly under stress conditions (Haapaniemi2017Combined).

## Clinical Significance
Mutations in the HYOU1 gene are associated with a novel immunometabolic syndrome characterized by combined immunodeficiency and hypoglycemia. Patients with these mutations exhibit increased susceptibility to bacterial and herpetic infections, stress-induced hypoglycemia, and various immunological abnormalities, including granulocytopenia and deficiencies in B cells and dendritic cells (Haapaniemi2017Combined). The mutations identified in the HYOU1 gene are compound heterozygous missense mutations located in the ATPase domain, which are believed to impair ATP hydrolysis and affect the chaperone function of the protein, leading to altered substrate binding and ectopic protein interactions (Haapaniemi2017Combined).

These genetic alterations result in disrupted cellular metabolism, enhanced protein synthesis, and altered glucose metabolism and redox enzyme transcription, as evidenced by RNA sequencing and mass spectrometry analyses (Haapaniemi2017Combined). Electron microscopy studies have shown increased mitochondrial numbers and high reactive oxygen species production in patient neutrophils, suggesting impaired mitochondrial function and altered redox balance as contributing factors to the disease phenotype (Haapaniemi2017Combined). Treatment approaches such as GM-CSF and IVIG have been effective in managing some of the immunological symptoms, such as neutropenia and infection rates (Haapaniemi2017Combined).

## Interactions
HYOU1, also known as hypoxia-upregulated protein 1, is involved in various protein interactions, particularly under stress conditions. It is an endoplasmic reticulum (ER)-resident chaperone protein that interacts with viral interleukin-6 (vIL-6) of Kaposi's sarcoma-associated herpesvirus (KSHV). This interaction enhances vIL-6 function by increasing its intracellular levels and promoting its interaction with gp130, a component of the STAT3 signaling pathway. HYOU1 facilitates vIL-6-induced STAT3 phosphorylation, which is crucial for the activation of the JAK/STAT signaling pathway and vIL-6-mediated biological functions such as endothelial cell migration and survival (Giffin2014Modulation).

HYOU1 also interacts with human interleukin-6 (hIL-6) when hIL-6 is modified with an ER-targeting KDEL motif, allowing it to coimmunoprecipitate with HYOU1. This interaction is not observed with wild-type hIL-6 due to its rapid secretion. HYOU1 knockdown decreases STAT3 phosphorylation mediated by both vIL-6 and hIL-6, indicating its role in modulating IL-6 signaling events (Giffin2014Modulation).

In the context of high-altitude pulmonary edema, HYOU1 is associated with specific single nucleotide polymorphisms (SNPs) and interacts with transcription factors, suggesting its involvement in stress management and hypoxia tolerance (Sharma2021Highaltitude).


## References


[1. (Giffin2014Modulation) Louise Giffin, Feng Yan, M. Ben Major, and Blossom Damania. Modulation of kaposi’s sarcoma-associated herpesvirus interleukin-6 function by hypoxia-upregulated protein 1. Journal of Virology, 88(16):9429–9441, August 2014. URL: http://dx.doi.org/10.1128/jvi.00511-14, doi:10.1128/jvi.00511-14. This article has 36 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/jvi.00511-14)

[2. (Sharma2021Highaltitude) Kavita Sharma, Aastha Mishra, Himanshu N Singh, Deepak Parashar, Perwez Alam, Tashi Thinlas, Ghulam Mohammad, Ritushree Kukreti, Mansoor Ali Syed, and M A Qadar Pasha. High-altitude pulmonary edema is aggravated by risk loci and associated transcription factors in hif-prolyl hydroxylases. Human Molecular Genetics, 30(18):1734–1749, May 2021. URL: http://dx.doi.org/10.1093/hmg/ddab139, doi:10.1093/hmg/ddab139. This article has 7 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddab139)

[3. (Haapaniemi2017Combined) Emma M. Haapaniemi, Christopher L. Fogarty, Salla Keskitalo, Shintaro Katayama, Helena Vihinen, Mette Ilander, Satu Mustjoki, Kaarel Krjutškov, Markku Lehto, Timo Hautala, Ove Eriksson, Eija Jokitalo, Vidya Velagapudi, Markku Varjosalo, Mikko Seppänen, and Juha Kere. Combined immunodeficiency and hypoglycemia associated with mutations in hypoxia upregulated 1. Journal of Allergy and Clinical Immunology, 139(4):1391-1393.e11, April 2017. URL: http://dx.doi.org/10.1016/j.jaci.2016.09.050, doi:10.1016/j.jaci.2016.09.050. This article has 15 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.jaci.2016.09.050)